Information for Healthcare Professionals

The VizMark VM1 tissue marker is a permanent, fully implantable device designed for marking suspicious breast lesions and biopsy sites.

It is specifically optimized for long-term, multi-modality imaging in high-risk patients, particularly women requiring multiple imaging procedures such as mammography, ultrasound, CT scanning, and MRI. The device provides an innovative solution for healthcare professionals managing complex patient cases.

VM-1 designed use

Permanent, fully implantable and well-visualized.

Marking of the site of collection of a breast biopsy
Permanent marking of suspicious lesions of the breast
VizMark VM1 is specifically designed and developed to be visible under MRI and provide a complete imaging solution for long-term care for women of high-risk who will undergo multiple imaging modality care.

VM1 provides an improved and enhanced signal under MRI.
Applicator Specifications

Vizmark VM1 is supplied as a sterile packed and preloaded, single-use applicator.

The marker is placed in the tissue under the applicable imaging modality selected by the healthcare professional including Mamo, ultrasound, CT and MRI.

The delivery system device has a beveled 12 cm 14-gauge needle with 1 cm depth marks and a plunger.

Transforming Breast Cancer Care with VM-1 Smart Visual Markers

At VizMark, we’re dedicated to improving patient outcomes and empowering medical professionals with technology that makes a difference.

Join the Revolution in Women’s Health

As VM-1 sets a new standard for post-biopsy care, we’re not just improving technology—we’re improving lives.

About VizMark

Our team, led by radiologist and women’s health advocate Dr. Michael T. Nelson, created VM-1 improve imaging under MRI necessary for high risk patients. Through years of research and collaboration, we’ve designed a marker that eliminates the challenges of traditional solutions, offering better outcomes for patients and providers alike.

Dr. Michael Nelson
Founder and primary inventor, Dr. Nelson is a Board-Certified Radiologist, former U.S. Navy Flight Surgeon, and Professor of Radiology at the University of Minnesota. A leader in Mammography, Interventional Radiology, and Women’s Health, he co-founded the Jane Brattain Breast Center at Park Nicollet Medical Center.

Dr. Michael Nelson

Founder, Chief Medical Officer, and radiology expert

Kim Nelson
Accomplished senior executive and board member with 30+ years in high-tech, leading business growth, revenue expansion, and successful exits, including roles at Oracle and Primus Knowledge (IPO).

Kim Nelson

CEO with a proven track record of driving innovation

Tom Murphy
With 30+ years in medical device sales, operations, and management, Mr. Murphy has deep expertise in the tumor marker space, leading operations and sales at Mermaid Medical, Argon Medical, and Angiotech.

Tom Murphy

VP of Operations, tumor marker specialist

Steve Karel
A biotech senior executive with startup experience, Mr. Karel has held roles as CEO, CFO, and SVP of Business Development. He brings expertise in finance, fundraising, corporate development, and R&D, strengthening VizMark’s operations and growth.

Steve Karel

CFO with deep expertise in medical finance